workplace drug testing
To understand the principles behind drug
testing technology, some knowledge is required about the way in which the
body deals with chemical compounds such as drugs. Irrespective of the
method of intake, all drugs, pharmaceutical and otherwise, undergo a
series of bio-chemical reactions in the body. These reactions release the
active compound and then gradually degrade the drug into slightly
different structures. These structures, also called metabolites, are then
excreted from the body in a variety of ways.
What do labs test for?
The first thing to know about drug
testing is what the standard test looks for. What is being tested for
varies greatly based on testing company, expense, expectations, federal
requirements etc. Following is a description of what to expect from the
standard drug
testing.
Marijuana, cocaine (including crack),
opiates (including heroin), methamphetamine, phencyclidine (PCP or angel
dust), and ecstasy (MDMA). These drugs were identified as "illegal
drugs" in the Presidents Executive Order 12564 and are the five drugs
mandated for workplace drug testing by the federal government
The NIDA 5 Federal government guidelines
(by NIDA-The National Institute on Drug Abuse and SAMHSA-The Substance
Abuse and Mental Health Services Administration) require that companies
which use commercial class drivers licenses for employees must have a drug
testing system in place. Among other things, this required drug
testing program
must test for 5 specific categories of drugs (sometimes referred to as the
"NIDA 5"). Because of this federal requirement, most drug
testing companies offer a basic drug test which checks for drugs in these
5 common categories. Click on the substance name for a description of the
laboratory method for detecting the substance.
- Cannabinoids (marijuana, hash)
- Cocaine (cocaine, crack,
benzoylecognine)
- Amphetamines (amphetamines,
methamphetamines, speed)
- Opiates (heroin, opium, codeine,
morphine)
- Phencyclidine (PCP)
Most workplace drug testing companies also offer an
expanded test which includes a few additional drugs in the testing
process. Most do not add all of these in their expanded test, but choose a
different combination of 3 or 4 to add :
- Barbituates (Phenobarbital,
Secobarbitol, Butabital)
- Hydrocodone (Lortab, Vicodin)
- Methaqualone (Qualuudes)
- Benzodiazepines (Valium, Librium,
Serax, Rohypnol)
- Methadone
- Propoxyphene (Darvon compounds)
- Ethanol (Alcohol)
Urine workplace drug testing
Urine workplace drug testing is the most common type. Urine is the specimen of choice since it contains the most
metabolites of a drug taken. Urine is the main excretory route for drugs
and their metabolites. The following is a summary of the analytical
methods used by laboratories to detect the presence of drugs or their
metabolites in the urine:
These drug
testing procedures are most commonly used to
screen samples. In the event that drugs or their metabolites are detected,
then the sample is normally tested again using an even more sensitive test
such as Gas Chromatography and Mass Spectometry. Immunoassays work on the
principle of antigen-antibody interaction. Antibodies are chosen which
will bind selectively to drugs or their metabolites. The binding is then
detected using either enzymes, radioisotopes or fluorescent compounds.
EMIT (Enzyme Multiplied Immunoassay
Technique) is manufactured by Syva Laboratories. It uses an enzyme as the
detection mechanism. It is the cheapest, simplest to perform and the most
widely used of the immunoassays. The EMIT is commonly used by employers as
an initial drug
testing step. The EMIT is the most commonly used test for
pre-employment screenings despite having a 4-34% "false
positive" rate.
RIA (Radio Immunoassay) is manufactured
by Roche Diagnostics. It is similar to EMIT but uses a radioactive isotope
such as iodine instead of an enzyme. However, because it involves using
radioactive substances, it is less popular than EMIT. This is a highly
sensitive form of workplace drug testing mainly used by the military. Mistakes come from
poor calibration. The manufacturer states that “a positive test result
should be confirmed…”
FPI (Fluorescence Polarization Immunoassay) is manufactured by Abbott
Laboratories. Fluorescent compounds mark the selective binding of
antibodies to drugs and their metabolites. It is a highly sensitive and
highly specific type of drug
testing.
TLC (Thin Layer Chromatography)
This drug
testing procedure involves the addition of a solvent to the sample causing
the drugs and their metabolites to travel up a porous strip leaving color
spots behind. As each different substance travels a specific distance, the
strip can then be compared with known standards. This type of drug
testing gives no
quantitive information, it merely indicates the presence of drugs or their
metabolites. Furthermore, it relies on the subjective judgment of a
technician and requires considerable skill and training. False positives
result from misinterpretations. It is not widely used.
GC/MS (Gas Chromatography/Mass Spectometry)
This is the most precise type of drug
testing for identifying and quantifying
drugs or their metabolites in the urine. The GC/MS is routinely used as a
confirmation test following a positive result on an Immunoassay. It
involves a two step process, whereby Gas Chromatography separates the
sample into its constituent parts and Mass Spectometry identifies the
exact molecular structure of the compounds. The combination of Gas
Chromatography and Mass Spectometry is considered to be the definitive
method of establishing the presence of drugs or their metabolites in the
urine. However, the equipment necessary to perform it is extremely
expensive and this is reflected in the price for workplace drug testing each sample.
Occasionally problems do arise with poor calibration of the equipment.
Mistakes also commonly happen if the machine is not thoroughly cleaned –
samples can be contaminated by small traces from the previous urine drug
testing sample. Temperature, pressure, and storage time of samples must be rigidly
controlled.
Although urine is most commonly tested,
occasionally laboratories use one of the following methods to detect the
presence of drugs or their metabolites:
Hair Follicle workplace drug testing
workplace drug testing
The technology behind the hair drug
testing was
pioneered by Psychemedics Corporation in 1987. Psychemedics Corporation is
the world's leading laboratory for the workplace drug testing of hair for the presence of
drugs. Its client list includes over 2,200 corporations (over 10% of the
Fortune 500), which use hair workplace drug testing as part of their drug-free workplace
programs. In addition, five of the country's largest police departments as
well as schools and Federal Reserve Banks rely on Psychemedics' hair
testing.
When drug metabolites are circulated in the blood, they enter the scalp's
blood vessels and are filtered through the hair. These metabolites remain
in the hair and provide a permanent record of drug use. With a one-inch
hair sample containing about 50 strands, labs can detect the use of drugs
within the past three months.
A standard screen covers a period of
approximately 90 days. The hair drug
testing sample is cut as close to the scalp as
possible and the most recent 3.9 centimeters (approximately 1 1/2 inches)
are tested. The hair sample is cut as close to the scalp as possible and
the most recent 3.9 centimeters (approximately 1 1/2 inches) are tested.
Assuming the sample is taken from the head, the amount of hair needed is a
snip about the thickness of a shoelace tip.
Hair can be collected from several
locations on the head and combined to obtain the required amount of hair.
If necessary, body hair can be used as an alternative to head hair. If you
have very short hair, labs can take a drug
testing sample from any part of the body.
Psychemedics Corporation (Amex: PMD)
announced today it has received 510(K) clearance from the Food and Drug
Administration (FDA) for its drug
testing detection of marijuana use
through human hair analysis. Psychemedics has now received FDA clearance
for the five drug panel routinely used in workplace drug
testing.
Psychemedics' marijuana drug
testing system
employs radioimmunoassay for the qualitative screening and mass
spectrometry for quantification of carboxy -- THC in hair for the purpose
of identifying marijuana use.
The hair is clipped and then dissolved in
a series of solvents. Psychemedics' patented technology that detects drugs
in hair using radioimmunoassay. RIAH® (Radioimmunoassay of Hair) measures
the drug molecules permanently entrapped in hair which were incorporated
following ingestion. The laboratory then analyzes the liquified sample
using Gas Chromatography and Mass Spectometry. This makes it a highly
sensitive test, yet the considerable cost and prolonged process means that
it isn't often used. It also usually requires a confirmation test using
urine.
People with dark hair are 10-50 times
more likely to test positive for drug use. Hair drug
testing is widely used in
the casino industry. Companies such as Blockbuster Video and Subway
perform hair follicle workplace drug testing on all employees. Pschemedics markets
their PDT-90 hair drug
testing collection kit to parents to be a deterrent to drug
use and to tell whether a child has used drugs in the previous several
months. The PDT-90 is available in some pharmacies and drugstores.
Perspiration workplace drug testing (Sweat Patch)
PharmaChem has produced a drug
testing patch which is
worn on the skin for a period of time. The patch contains a mechanism
which is able to detect the presence of drugs or their metabolites as they
are excreted in the individual's perspiration. The drug
testing patch is used mainly to
monitor individuals who are on parole or probation. The use of the sweat
patch to detect drug use was recently approved by the FDA. The patch is
used mainly to monitor people on parole or probation. The drug
testing patch is tamper
proof and each one has a serial number.
Saliva workplace drug testing
The FDA has recently given Epitope,
Inc approval to begin manufacturing saliva drug
testing. In a study using RIA
(Radioimmunoassay) test, cannabinoids were detected in saliva 4 to 10
hours after subjects smoked a single marijuana joint. Epitope has recently
developed a test which detects drugs or their metabolites in saliva.
However, this sort of drug
testing is limited to detecting very recent drug use.
In one study, saliva testing was only able to detect cannabinoids 4-10
hours after the subjects had been smoking. It is likely that this drug
testing
will be confined to detecting current intoxication only.
“Saliva workplace drug testing has been touted as a
"fitness for duty" test, as its window of detection begins as
soon as a drug is ingested. Saliva drug
testing will reveal only current or very
recent (within the past twelve hours) marijuana use, but will detect use
of cocaine, opiates, methamphetamine and Ecstasy over the past two to
three days (urine will detect these drugs for three or four days after
use). Saliva is typically experienced as cleaner and less intrusive than
urine, and there are currently no known methods for defeating saliva workplace drug testing. Saliva
drug
testing testing is useful for pre-employment, random,
post-accident and for-cause testing. Both lab-based and on-site systems
are available; the on-site system offers results ten minutes after taking
the saliva sample. Saliva tests compare favorably in price to urine
testing. "
In oral fluid, drugs will be detected
within minutes after use.
In urine drug
testing, drugs will remain undetected in
the first 4-8 hours.
- Marijuana 12-24 hrs
- Opiates 24-48 hrs
- Amphetamine 24-48 hrs
- Methamphetamine 24-48 hrs
- Cocaine 12-24 hrs
Saliva workplace drug testing for drugs of abuse can
provide both qualitative and quantitative information on the drug status
of an individual undergoing testing. Self-administration by the oral,
intranasal, and smoking routes may result in contamination of the oral
cavity. Generally, the level of drug detected in the oral cavity is
related to the relative acidity of the saliva and there are established
chemical relationships that can be used to estimate the blood level once
the saliva level and its relative acidity are known. Since there is a high
correlation of saliva drug concentrations with plasma, the application of
saliva workplace drug testing for drugs of abuse may be successfully utilized in a
variety of applications, including the following:
- Detection - employment, health exams,
insurance
- Treatment - diagnosis, compliance,
abstinence
- Forensics - reasonable suspicion
testing, DUI, evidence investigation
LifePoint,
Inc. – IMPACT System
The use of saliva as the specimen of choice adds significant advantages to
the LifePoint IMPACT Test System when used for workplace drug testing for drugs of abuse.
Saliva offers the ability to obtain "current status" or
"blood-equivalent" information for drugs of abuse, compared to
urine workplace drug testing results, which indicate prior drug use by an individual over
2-5 days. This is a very significant advantage since only a blood test
done with sophisticated laboratory equipment can provide similar
information. This advantage is extremely relevant in the initial market
segments being targeted.
- Saliva is the only easily obtainable
specimen in which the measured level of many analytes correlates with
their corresponding levels in blood.
- Using saliva as a specimen provides
for non-invasive and observable specimen collection compared to blood
(invasive) and urine (not easily observable) as specimen types.
- Saliva is a "natural fit" as
a specimen of choice for on-site testing.
Previous attempts to use saliva as a test
specimen have been limited to the use of absorption as a collection
methodology. Absorption has significant limitations, including a slow
collection time and potential loss of an analyte due to absorption in the
collection pad. Additionally, collection for transport to lab does not
allow for quantitative workplace drug testing because the originally collected volume of
saliva is not known. Current on-site workplace drug testing is often limited to a single
test because multiple tests require large amounts of saliva.
workplace drug testing
There are two initial drug
testing panels to
choose from. The first panel performs the National Institute on Drug Abuse
(NIDA) 5 drugs (marijuana, cocaine, PCP, amphetamines/methamphetamines,
and opiates). The second panel performs the NIDA-5 drugs plus alcohol.
We will rapidly expand the test menu.
Future drug tests include Benzodiazepines, Barbiturates, Ecstasy, and TCA
(tri-cyclic antidepressants). These will be available in a wide variety of
panel formats to meet market requirements.
The drug
testing instrument allows you to obtain a
near-simultaneous saliva sample to send to a laboratory for GC/MS
confirmation.
The drug
testing system has all the necessary
attributes to become "evidentiary" (i.e., instrument read,
outstanding quality of result, etc.), and meets the Frye and Daubert
standards for court admissibility. However, since the system is just
coming to market, it has not yet been tested in a court case.
Saliva collection AND workplace drug testing with the
IMPACT Test System take less than 5 minutes.
LifePoint will be submitting our alcohol
test for DOT approval as an evidentiary test. The DOT has not yet approved
any on-site or saliva products for workplace drug testing. However, SAMHSA
guidelines are being reviewed to include saliva and on-site tests as
acceptable by DOT.
LifePoint has initially targeted the law
enforcement, industrial workplace and emergency room markets.
AVITAR INCORPORATED
- ORALscreen
ORALscreenTM is the first rapid on-site oral fluid screening device for
drugs of abuse testing. ORALscreen uses Avitar's proprietary polyurethane
and oral fluid technology to detect up to four classes of drugs of abuse
(opiates, marijuana, cocaine, and methamphetamine - including MDMA/Ecstasy).
It takes only fifteen minutes to obtain accurate drug
testing results.
Orasure
Technologies, Inc. - Intercept
The Intercept™
oral fluid drug test was introduced in February as a collaborative effort
of LabOne, STC Technologies, Inc., and Epitope, Inc. (NASDAQ: EPTO). All
three drug
testing companies play pivotal roles in the marketing of this new lab
service. STC, the leader in oral fluid immunoassay technology, provides
reagents as well as marketing support. Epitope produces the Intercept™
collection device and provides sales support for the criminal justice and
public health markets. Laboratory workplace drug testing, result report, workplace sales,
and account management support are assumed by LabOne.
In partnership with several leading lab partners, OraSure Technologies
markets Intercept®, the first laboratory-based oral fluid drug test. The
Intercept® test serves the workplace and criminal justice workplace drug testing
markets.
Blood workplace drug testing
Although expensive and intrusive, blood
workplace drug testing is the most accurate confirmation of drug use. Since blood
workplace drug testing
accurately detects the presence of the drug or its metabolites at the time
of testing, the results from this type of test are the best indication of
current intoxication. Blood workplace drug testing for the use of drugs is primarily used
in accident investigations and for health insurance or life insurance
exams. Marijuana can be detected up to six hours after consumption by
testing blood; after that, the metabolite concentration falls rapidly, and
cannabinoids are not detectable in the blood after 22 hours.
Fingernail Analysis
Fingernails, like hair, are made of the
protein keratin. Results of a fingernail sample will represent drug use
that is approximately 4-5 months from the time of ingestion. Fingernails
can be clipped, or, if length does not allow, can be shaved in a safe and
pain-free sample collection.
Eye workplace drug testing
The eye test is made by PMI
Incorporation, based in Maryland. The test consists of a pair of goggles
hooked up to a computer, and it uses light to measure pupil size and
reflex to light. The readings are compared against a previously
established baseline, and if the pupil is dilated or reacts more slowly
then the test shows positive. The eye scan can only determine if the
person is currently impaired and can not determine if impairment is caused
by drugs, alcohol, and lack of sleep or other causes. Generally, a person
that tests positive on an eye drug
testing scan will be subjected to a subsequent
urinalysis to determine what toxin is causing the impairment. Two other
similar tests, the EM/2 and FIT tests measure the rapid eye movement of
the pupil. The drug
testing manufactures claim a 97% accuracy rate. Problems with eye
or nerve abnormalities raise questions about test accuracy.
workplace drug testing
|
Email Us 24 Hours
A Day here. |
|
Call Us Toll Free
24 Hours A Day:
1-877-DETOXIFY (1-877-338-6943) |
200%
Guarantee / Product
Index / Value
Packs
Detection
Info / FAQ'S
/ Secure
Orders / Your
Privacy
Testimonials
/ Order By
Mail / Link
To Us / Contact
Us
Return
To Top / Return
To Main
info@passing-drug-test.com
Passing-Drug-Test.Com is a registered
trademark of Exe Productions
©1999-2003, All Rights Reserved Passing-Drug-Test.Com is
a proud
authorized distributor of Clear Choice products.
|